Trials / Completed
CompletedNCT00384436
Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 580 (estimated)
- Sponsor
- Forest Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of escitalopram to an active comparator in severely depressed patients
Detailed description
Escitalopram is the S-enantiomer of citalopram. Both escitalopram and citalopram are selective serotonin reuptake inhibitors (SSRIs) and are used to treat depression in adults. This study is designed to evaluate the safety and efficacy of escitalopram and an active comparator in severely depressed patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | escitalopram |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2007-10-01
- First posted
- 2006-10-06
- Last updated
- 2008-01-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00384436. Inclusion in this directory is not an endorsement.